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ABSTRACT
This study aimed to investigate a methodology for discriminating viable and non-viable 
T. gondii oocysts in water. Analyses included two steps: (i) microscopic investigation with 
vital dyes; (ii) molecular investigation, using a real time PCR (qPCR), after parasite treatment 
(or not) with propidium monoazide (PMA). The method was called qPCR-PMA. Oocyst 
aliquots were incubated (15 min) at 25 ºC or 100 ºC and analyzed by microscopy, after trypan 
blue and neutral red staining. Microscopic investigation determined viable and non-viable 
oocysts. For the molecular investigation, both aliquots of oocysts were treated with PMA. 
Non-viable oocysts, after PMA treatment, exhibited an inhibition of DNA amplification by 
qPCR. Although analyses were carried out with oocysts treated experimentally, these results 
suggest that qPCR-PMA can be a useful strategy to distinguish viable and non-viable T. gondii 
oocysts in water safety testing, showing if water is safe to drink.
KEYWORDS: Viability. Toxoplasma gondii. Oocysts. Vital dyes. Propidium monoazide. 
Real time PCR.
INTRODUCTION
Waterborne parasites affect many populations in the world, especially in 
outbreaks. In the last years, various factors were related to dissemination of these 
pathogens such as, increased contamination of drinking water and food; increase 
of susceptible people; changes in the drinking water treatment technology; 
and globalization1. The high morbidity and mortality of populations caused 
by contaminated drinking water have been relevant in the last years. Thus, this 
condition must be controlled by improving the quality and the safety of drinking 
water2,3.
Among the main waterborne parasites, Toxoplasma gondii affects about a third 
of the world population4. T. gondii is an obligate intracellular parasite that infects a 
wide range of warm-blooded vertebrates (mammals and birds) as intermediate hosts, 
in which the asexual cycle takes place with formation of tissue cysts within cells. 
The felines are the definitive hosts of this protozoan, whose sexual cycle culminates 
with the production of oocysts eliminated in the feces thereafter contaminating the 
environment5-7.
Although the majority of toxoplasmosis cases is asymptomatic, around 10-20% 
of infected individuals can develop the ocular form of toxoplasmosis associated with 
congenital infections or acquired after birth. In immunocompromised individuals, 
the infection may cause serious destructive inflammatory lesions in the central 
nervous system, known as cerebral toxoplasmosis7-10. Other important clinical and 
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social implications have been reported in association with 
schizophrenia and bipolar disorder11-15. 
The main routes of T. gondii transmission includes 
the transplacental, from the mother to the fetus during the 
primary infection; the ingestion of cysts present in infected 
animal tissues; and the ingestion of water or contaminated 
food by oocysts16,17.
Unsporulated oocysts are subspherical to spherical with 
walls composed of two colorless layers. Polar granules are 
absent, and the sporont almost fills the oocyst. Sporulation 
occurs outside the definitive host, within 1 to 5 days of 
excretion depending upon the environment aeration and 
temperature5,7,18.
Sporulated oocysts are subspherical to ellipsoidal and 
contain two ellipsoidal sporocysts. In this phase, oocysts 
are viable for at least one year, resisting to temperatures 
between 20 °C and 37.5 °C. They survive and remain 
infective for 12 to 18 months in ideal environmental 
conditions depending on the humidity, temperature and 
shading place conditions. Sporulated oocysts maintained 
in laboratory can remain infective at 35 °C for 32 days, at 
40 °C for 9 days, and at 45 °C for 1 day. They survive at 
4 °C for 54 months, and frozen at -10 °C for 106 days18,19.
Oocysts can survive in water for long periods and are 
highly resistant to several chemical inactivation processes. 
This property favors the occurrence of many outbreaks 
caused by T. gondii in different world regions. Most of them 
are associated with water contamination by oocysts20-23.
Although the polymerase chain reaction (PCR) has 
contributed significantly to the diagnosis of toxoplasmosis 
in clinical samples, the viability of oocysts in water samples 
collected in places where outbreaks have occurred are not 
well established. The water safety can be reduced by a low 
detection of viable pathogens. Therefore, it is important 
to determine the parasite viability in water. In general, the 
usual approach is the parasite analysis in light microscopy 
after the sample staining by vital dyes.
Recently, a useful strategy to identify live pathogens 
in food or water has been described, the use of propidium 
monoazide (PMA) that is a photoreactive DNA-binding dye. 
Dead pathogens lose the ability to keep their membranes 
intact. Thus, DNA is free in cytosol, ready to react with 
PMA that can penetrate in membrane-compromised cells. 
Live pathogens are not exposed to PMA, as they have intact 
cell membranes. The qPCR-PMA includes DNA extraction 
and real time PCR (qPCR) amplification of PMA-treated 
samples to efficiently detect non-viable pathogens24-26.
This study was aimed to investigate a methodology 
for discriminating viable and non-viable T. gondii oocysts 
in water. In order to identify whether only a molecular 
method could be efficient in this situation, we analyzed two 
methods. The first one was the microscopic investigation 
after parasites treatment with vital dyes. The second 
one was the molecular investigation, using qPCR-PMA, 




Stool samples containing non-sporulated oocysts of cats 
experimentally infected with T. gondii (Br1 strain) were 
collected in the Centro de Ciencias Agrarias, Departamento 
de Medicina Veterinaria Preventiva, Universidade Estadual 
de Londrina, Parana State, Brazil. After the stool samples 
collection, they were kindly provided for this study and were 
maintained at 4 °C, including the period of transportation 
to our laboratory.
Purification and concentration of T. gondii oocysts
T. gondii non-sporulated oocysts were isolated, purified 
and concentrated from stools by flotation and centrifugation 
using sucrose. During all laboratory steps, oocysts were 
maintained at 4 °C to prevent sporulation. Cat stools (3 g) 
were mixed with saturated sucrose solution (10 mL), 
vigorously stirred for 30 s, and centrifuged at 400 x g for 
20 min at 4 °C. The upper layer of the supernatant (4 mL) 
was transferred to a new tube and washed (4700 x g for 
5 min) in distilled water (10 mL). 
Purified oocysts (in 10 mL) were counted in a Neubauer 
chamber. The recuperation of oocysts was 2.3 x 105/mL. 
Firstly, oocysts were used to establish a standard qPCR 
curve. Next, oocysts were divided into 2 aliquots of 500 μL 
to be used in the experiments. One aliquot was incubated 
at 25 °C for 15 min, and the second aliquot was incubated 
at 100 °C for 15 min. Then, both aliquots were stored at 
4 °C until and used in the staining and photo-activation 
experiments. 
Oocyst treatment with vital dyes
Viability of T. gondii oocysts was, firstly, tested using 
trypan blue 0.4%, which dyes only cells with damaged 
external membrane. Both oocyst aliquots (incubated at 
25 °C and at 100 °C) were stained with trypan Blue 0.4% v/v 
at room temperature for 15 min. In addition, both aliquots 
were stained with 2.0% neutral red that dyes only viable 
cells. Oocysts were incubated with 2.0% v/v neutral red, at 
room temperature in a dark room for 3 h. A volume of 20 μL 
of each aliquot was added to glass slides and coverslips and 
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analyzed in a 400-fold magnification using a Zeiss® Primo 
Star optical microscope (Jena, Germany). 
Oocyst treatment with PMA
For PMA treatment, experiments were performed as 
described before24-26. Three aliquots at concentrations 
of 2.3 x 105/mL were tested. The first and second were 
composed of oocysts incubated at 25 °C and at 100 °C, 
respectively. The third aliquot was composed of a mix 
containing viable and non-viable oocysts (v/v). Then, the 
mixture was divided into 2 aliquots and only one was treated 
with PMA. Both aliquots were serially diluted (1:1, 1:2, 1:4, 
1:8 and 1:16). Each dilution was amplified by qPCR-PMA, 
after DNA purification. The aim of the third aliquot testing 
was to determine the DNA concentration capable of 
distinguishing viable and non-viable oocysts after PMA 
treatment. In order to determine the DNA concentration of 
oocysts, a standard curve was constructed for the REP-529 
primer set (see Real time PCR item).
To each aliquot (180 μL), 20 μL of PMA 2 mM were 
added (Biotium Inc., Hayward, WI, USA) to obtain a final 
concentration of 200 μM. For the controls, one tube of each 
aliquot received water instead of PMA. The solutions were 
maintained in a dark room for 30 min at room temperature. 
For PMA photoactivation, the tubes were packed in a plastic 
bag containing fragmented ice (ice bed) at a distance of 
approximately 15 cm from each other, and they were 
exposed to white light for 30 min. A 500 W halogen lamp 
was used for the light emission. Next, these aliquots were 
used for DNA purification and qPCR.
DNA purification
Oocyst aliquots (200 μL) were digested for 12 to 18 h 
at 56 °C with proteinase K (20 μg) in 40 μL of AL buffer 
(QIAGEN) ) under agitation. DNA was extracted using the 
QIAamp DNA Mini Kit (QIAGEN, Hilden, Germany). The 
protocol was performed according to the manufacturer’s 
instructions. DNA concentration and purity were determined 
by the ratio of the reading at 260 nm wavelength divided by 
the reading at 280 nm in the NanoDrop ND 1000 (Thermo 
Fisher Scientific, Waltham, USA). DNA samples were 
diluted in ultra-pure water until a concentration of 100 ng/μL 
for use in qPCR27. 
Real time PCR (qPCR)
Reactions were performed as previously described27,28. 
The primer set used for qPCR amplified a fragment of 
112-bp of a highly repetitive sequence named REP-529, 
which has 200-300 copies per T. gondii genome29. 
The qPCR primer set is composed of a forward primer 
(5’ –AGAGACACCGGAATGCGATC T- 3’), and a 
reverse one (5’-TTCGTCCAAGCCTCCGACT-3’) 
p r i m e r s  a n d  h y b r i d i z a t i o n  p r o b e 
(5’-TCGTGGTGATGGCGGAGAGAATTGA-3’) labeled 
with FAM and BHQ1. The reactions were performed in 
a final volume of 20 μL. DNA samples (3 μL of DNA 
containing up to 100 ng/μL), a control DNA (5 ng/μL) and 
DNA dilutions to construct the standard curve (3 μL for each 
point) were added to the reaction mixture containing 10 μL 
of 2 X TaqMan Universal PCR Master Mix; 1.25 μL of the 
other reagents mix (18 μM of forward and reverse primers 
and 5 μM of the hydrolysis probe). Each amplification 
run contained two negative controls (ultra-pure water 
and a human toxoplasmosis-negative DNA sample). 
Amplifications were performed in an Applied Biosystems 
7500 Real-time PCR System using the following thermal 
profile: 2 min, 50 °C, and 95 °C for 10 min. Next, 40 cycles 
were performed at 95 °C for 15 s and 60 °C for 1 min.
The standard curve for REP-529 primer set was 
constructed testing six DNA concentrations obtained from 
1 x 106 oocysts containing 50 ng/μL. Serial dilutions ranged 
up to 10 oocysts. Cycle quantification values (Cq) were 
plotted as the mean of triplicates. Parasite concentrations 
were determined after the calculation of the linear regression 
equation (y = ax + b), where y = Cq; a = slope curve; 
x = parasite number in log
10
; b = the point in which the 
curve intersects the y-axis (y intercept)30,31.
Comparison of the number of oocysts after qPCR 
amplification, between PMA-treated or non-treated samples 
were statistically evaluated by the GraphPad Prism Software 
(version 6.0, Prism Software Inc., San Diego, CA, USA). 
The coefficient of similarity between both groups was 
calculated by the one-tailed unpaired Student’s t-Test with 
a 95% confidence interval. Differences were considered 
statistically significant when the p value was 0.05.
RESULTS 
Microscopic exams demonstrated that oocysts were 
totally preserved in the aliquot incubated at 25 °C. However, 
oocysts were ruptured in the second aliquot incubated at 
100 °C. To confirm these data, aliquots were dyed with 0.4% 
trypan blue. Preserved oocysts had whole wall surfaces 
without dye entry inside them (Figure 1A). On the other 
hand, Figure 1B shows oocysts after incubation at 100 °C 
presenting with deformities and dye penetration inside 
them after treatment with 0.4% trypan blue. At the same 
time, Figure 1C shows a viable oocyst impregnated with 
the 2.0% neutral red after an incubation period, confirming 
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the integrity of the oocysts wall. The oocysts incubated at 
100 °C were not stained with the neutral red, showing the 
unviability caused by the boiling treatment (Figure 1D). 
In addition, the viability of oocysts was tested by 
molecular methods. Firstly, a standard curve of REP-529 
primers was constructed testing DNA purified from oocysts. 
As shown in Figure 2A, the resulting standard curve 
displayed a R
2
 value = 0.995331, meaning that there is a 
high linearity among the variables. 
Figure 2B show the results of PMA-qPCR of oocysts 
treated or non-treated with PMA. Oocysts incubated at 
100 °C (non-treated) had walls rupture and their mean 
oocyst concentration was 1.75 x 105. In contrast, oocysts 
incubated at 100 °C and treated with PMA had a much lower 
qPCR-PMA amplification with a mean of oocysts of 33.5. 
According to the unpaired Student’s t-Test, the reduction 
of qPCR-PMA amplification was statistically significant 
(p = 0.0198).
DNA of oocysts incubated at 25 °C (treated or non-
treated with PMA) had a mean of oocysts in qPCR-PMA 
of 1.03 x 106 (non-treated) and 1.72 x 103 (treated). Even 
though, there was no significant statistical difference 
between both samples (p=0.4223). The next experiment 
was performed to identify whether qPCR-PMA differences 
observed in this experiment could be confirmed using 
oocysts serial dilutions. Figure 2C shows qPCR-PMA 
results of serial-diluted oocysts and PMA non-treated 
samples. However, these serial diluted and PMA-treated 
oocysts showed a significant qPCR-PMA inhibition when 
compared to those without PMA treatment. 
DISCUSSION 
T. gondii oocysts spread in the environment, including 
Figure 1 - Microscopic investigation: determination of the viability 
of oocysts. Images captured by light microscopy of purified 
oocysts with intact membranes after incubation at 25 °C for 
15 min, stained with trypan blue (A); and with neutral red (C). 
Images captured by light microscopy of purified oocysts 
after incubation at 100 °C for 15 min with damaged oocyst 
walls, stained with trypan blue (B); and with neutral red (D). 
Magnification: X 400. The arrows indicate oocysts. 
Figure 2 - Molecular investigation: determination of the viability 
of oocysts. (A) qPCR-standard curve of T. gondii oocysts using 
the REP-529 primer set with a hydrolysis probe FAM dye-
labeled. Results are shown as means of the cycle quantification 
value (Cq) obtained from triplicates of each DNA concentration. 
Analyses were carried out in 10-fold serial dilutions of DNA 
extracted from oocysts, in an initial concentration of 50 ng/μL 
(1 x 106 oocysts). R2= 0.9923; (B) qPCR-PMA: oocysts 
incubated at 25 °C or at 100 °C, non-treated (white bars) 
and PMA-treated (gray bars); (C) qPCR-PMA: two mixtures 
containing viable and non-viable oocysts, PMA-treated (gray 
circles) or non-treated (white circles) were serialyl diluted and 
qPCR was performed. Results in (B) and (C) represent the 
oocyst number derived from Cq values and calculated from 
the standard curve.
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water reservoirs, are an important source of infection for 
humans and animals. Consequently, this situation affects a 
great part of the world population20,21. 
The life time of oocysts has been investigated regarding 
their infectivity by means of experimental contamination of 
animals with soil samples. Nevertheless, viability of oocysts 
in the environment, such as water reservoirs has been poorly 
documented and this type of study can contribute to an 
effective monitoring of the quality of drinking water6,7,32.
The investigation of parasites viability should be included 
in T. gondii diagnosis in water samples, as only viable 
parasites are infective. This observation is important as some 
previously treated drinking water samples, may contain 
viable or non-viable oocysts. Thus, the knowledge on the 
viability of T. gondii oocysts is critical in public health to 
prevent the environmental transmission of parasites.
Incubation at 100 °C in short exposure times was unable 
to break through all the wall of the oocysts. After boiling 
(100 °C) for 15 min, some oocysts kept the walls intact. 
Both, trypan blue and neutral red dyes for microscopy 
exams are easy to do methods to observe oocysts with or 
without compromised walls. However, the observations 
must be performed by an experienced technician, as it is 
difficult to visualize oocysts on stained slides containing 
low parasite concentrations.
The difficulties encountered to achieve reliable and 
sensitive microscopy evaluations led different laboratories 
to study the efficiency of PCR (conventional or real-time), 
which has been shown as an important diagnostic tool. The 
molecular detection of T. gondii has been widely used to 
analyze clinical, veterinary and environment samples27,33. 
However, results are unable to determine whether the 
detected DNA came from viable or non-viable parasites34. 
This study chose to use the PMA, a photo-reactive DNA 
compound for the molecular investigation of the viability of 
oocysts. The qPCR-PMA is promising as it presents with 
good sensitivity and rapid results to discriminate viable 
and non-viable T. gondii oocysts26,35. The only flaw of this 
technique is the possibility of the amplification inhibition 
when PMA is present due to a lack of accessibility to DNA 
caused by the presence of DNA/PMA complexes. 
PMA penetrates into dead cells with damaged walls, 
then it is interleaved in nucleic acids after photoactivation. 
As the majority of natural DNA does not exist in cells, the 
number of molecules is reduced and Cq values increased25. 
In this way, only viable cells have intact DNA. 
T. gondii oocysts have a bilayered wall that surrounds 
the sporozoites. As a result, they are impermeable to water-
soluble molecules34,36. Previous studies demonstrated that 
the length of amplified DNA plays a crucial role in the 
suppression of qPCR-PMA37. Using qPCR, signals were 
suppressed in PMA-treated DNA from Giardia duodenalis 
cysts using a primer set that amplifies a 605-bp fragment, 
but suppression did not occur when a 77-bp product was 
amplified38. Similar results were shown in qPCR-PMA, 
whose primer sets amplified a 180-bp product, and the 
inhibition was observed in the case of a 834-bp product 
from the 18S gene of Cryptosporidium parvum oocysts39. 
In this study, the suppression effect of qPCR-PMA signals 
was not noticed, as described by Contreras et al.37 as 
reactions were performed using a primer set that amplifies 
a small fragment (112-bp) of T. gondii REP-529 sequence. 
In addition, REP-529 is a highly repetitive sequence 
with 200-300 copies in a single T. gondii genome. This 
methodology is highly used in clinical diagnosis27,28 and 
environment investigations40, due to its high sensitivity 
and specificity. Similarly, in the present study, qPCR-PMA 
was able to discriminate viable and non-viable oocysts with 
good efficiency. However, the discrimination of viable and 
non-viable oocysts was only possible after oocysts were 
sequentially diluted, as shown in Figure 2C.
CONCLUSIONS 
The qPCR-PMA methodology was efficient to 
determine the viability of T. gondii oocysts in water samples, 
although, in this study the analyses were carried out with 
experimentally ruptured oocysts. These data suggest that 
qPCR-PMA can be a useful strategy for distinguishing 
viable and non-viable T. gondii oocysts in water safety tests, 
showing if water is safe to drink.
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